Filter
1206
Filtered Results: 1206
Text search:
biomedical
and
health
research
Featured
Recommendations
112
New Publications
292
Language
Document type
No document type
661
Studies & Reports
240
Guidelines
147
Manuals
73
Strategic & Response Plan
45
Fact sheets
16
Training Material
14
Situation Updates
4
Infographics
4
Resource Platforms
1
Videos
1
Countries / Regions
India
70
Global
52
Rwanda
47
Liberia
35
Kenya
34
South Africa
30
Nigeria
25
Malawi
25
Africa
25
Ethiopia
24
Zambia
24
Latin America and the Carribbean
23
Uganda
23
Sierra Leone
21
Congo, Democratic Republic of
21
Nepal
13
Ghana
13
Zimbabwe
13
Mozambique
13
Ukraine
12
Western and Central Europe
12
Lesotho
11
Tanzania
11
Namibia
11
Burkina Faso
10
Guinea
9
Brazil
9
Cameroon
8
West and Central Africa
8
East and Southern Africa
8
Eastern Europe
8
Syria
7
Cambodia
7
Russia
7
South–East Asia Region
6
Colombia
5
Senegal
5
Asia
5
Botswana
5
Myanmar / Burma
5
Venezuela
4
Angola
4
South Sudan
4
Eswatini/ Swaziland
4
Peru
3
Armenia
3
Benin
2
China
2
Philippines
2
USA
2
Haiti
2
Guinea-Bissau
2
Belarus
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Bangladesh
2
Papua New Guinea
2
Indonesia
2
Iraq
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Mexico
1
Canada
1
Fiji
1
Afghanistan
1
Qatar
1
Lithuania
1
Germany
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
North America
1
Japan
1
Belgium
1
Mauritius
1
Argentina
1
Sudan
1
Yemen
1
Palestine
1
Georgia
1
Central African Republic
1
Chad
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
461
Clinical Guidelines
95
Public Health
64
Key Resources
43
Women & Child Health
32
Pharmacy & Technologies
32
Capacity Building
6
Toolboxes
HIV
160
COVID-19
95
Mental Health
82
TB
77
NTDs
58
Ebola & Marburg
54
Caregiver
44
Rapid Response
34
Pharmacy
30
Planetary Health
29
AMR
28
NCDs
24
Disability
23
Global Health Education
18
Conflict
17
Health Financing Toolbox
10
Specific Hazards
9
Refugee
7
Social Ethics
7
Natural Hazards
5
Zika
4
Polio
3
Cholera
1
Malaria
1
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st...
Epidemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A potentially fatal combination of newly-discovered ...
This publication provides information for identifying, classifying, marking, labelling, packaging, documenting and refrigerating infectious substances for transportation and ensuring their safe delivery.
The document provides practical guidance to facilitate compliance with applicable international...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
New data from the WHO reveal that an estimated 2.2 billion cases of malaria and 12.7 million deaths have been averted since 2000, but the disease remains a serious global health threat, particularly in the WHO African Region. According to WHO’s latest World malaria report, there were an estimated ...
The meeting was held from 26 to 27 March 2018 to review and discuss the following topics:
Advances and challenges in the use of fTLC, and new approaches to detecting mycolactone using monoclonal antibodies (mAbs).
The status of development of rapid diagnostic tests (RDTs) targeting the MUL...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The Rwandan Ministry of Health recognizes the threat that Non-Communicable Diseases (NCDs) pose to health and development in Rwanda and in 2009 articulates strategies to respond to them in the Health Sector Strategic Plan 2012 - 2018 (HSSP3). Among other things, the plan calls for a national prevale...
One health Response to AMR Containment.
In a significant move for the public health sector, Kerala has become the first state in India to launch an action plan to combat the growing cases of antimicrobial immunity, arising primarily from irrational use of medicines and excessive antibiotics used in...
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
Based on the survey, five principles for deinstitutionalization were identified: community-based services must be in place; the health workforce must be committed to change; political support at the highest and broadest levels is crucial; timing is key; and additional financial resources are needed.
Module 8
Site Planning
July 2017
Module 8: Site planning. This module is for people involved in organizing PrEP services at specific sites. It outlines the steps to be taken in planning a PrEP service and gives suggestions for personnel, infrastructure and commodities that could be considered...
In light of the decline in new Ebola cases, strategies are now needed to scale down the activities and bed capacities in Ebola care facilities. These facilities include Ebola treatment units, community care centres, Ebola treatment centres and isolation centres. The Governments of Guinea, Liberia an...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Based on WHO South-East Asia Regional Strategy on Autism Spectrum Disorder
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder and the issues faced by ...
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder and the issues faced by ...
